ClinicalTrials.Veeva

Menu

Validation of the Dutch Translation of the Tobacco, Alcohol, Prescription Medication and Other Substances (TAPS)-Tool

B

Birgit Seelen-de Lang

Status

Enrolling

Conditions

Substance Use
Severe Mental Disorder
Intellectual Disability, Mild

Treatments

Diagnostic Test: TAPS

Study type

Observational

Funder types

Other

Identifiers

NCT05273021
ECSW-2021-051

Details and patient eligibility

About

The aim of the study is to investigate the reliability and validity of the Dutch version of the TAPS-tool.

This will be investigated in 2 groups: patients without intellectual disabilities treated in Flexible Assertive Community Treatment (FACT) teams and patients with intellectual disabilities. For the later group, an adjusted version of the TAPS-tool will be developed.

For both groups the TAPS outcome will be compared to a golden standard.

Full description

All FACT teams in the participating organization (GGZ Oost Brabant) work through a standardized care pattern which implicates screening and assessment on several areas. At the start of the treatment all patients are assessed for intellectual disabilities, trauma related symptoms, addiction, quality of life, level of psychiatric complaints, social functioning, and phase of recovery. Subsequently quality of life and the level of psychiatric complaints is measured yearly. For this research question a small golden standard instrument was added to the standard screening and assessment.

For people with intellectual disabilities (ID) who get an extensive assessment of substance use problems in their (standard) treatment, permission to participate on the TAPS (version for ID) was asked.

Enrollment

150 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients treated in the participating FACT teams and for patients treated at the LVB-P (department for patients with intellectual disabilities and psychiatric disorders [Dutch name]) department of the GGZ Oost Brabant or the ORO foundation (ORO is no abbreviation but just a name of the institute).

Exclusion criteria

  • If patients do not have sufficient command of the Dutch language or cannot concentrate for 20 minutes, the instruments are not taken

Trial design

150 participants in 1 patient group

participants with substance use problems
Description:
There are 2 subgroups: * Participants without intellectual disabilities * Participants with intellectual disabilities with and without severe mental illness
Treatment:
Diagnostic Test: TAPS

Trial documents
4

Trial contacts and locations

3

Loading...

Central trial contact

Birgit Seelen, MSc; Cor de Jong, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems